For the Inventor, By the Inventor

Enter assignee name

Fremont, CA, United States of America

Protein Design Labs, Inc.

USPTO Granted Patents = 29

Forward Citations = 11,239

Loading Chart...

Loading Chart...

31 inventors (with patents filed for the assignee):

Cary L Queen (14 out of 18 patents)

J Yun Tso (6 out of 48 patents)

Harold E Selick (6 out of 13 patents)

4. Man Sung Co (5 out of 20 patents)

5. Kurt C Gish (4 out of 27 patents)

6. Nicholas F Landolfi (4 out of 19 patents)

7. David H Mack (4 out of 24 patents)

8. William P Schneider (3 out of 3 patents)

9. Maximiliano Vasquez (2 out of 68 patents)

10. Ellen L Berg (2 out of 18 patents)

11. David A Scheinberg (2 out of 49 patents)

12. Michael S Cole (2 out of 2 patents)

13. Naoya Tsurushita (1 out of 49 patents)

14. Ira H Pastan (1 out of 126 patents)

15. Chung Nan Chang (1 out of 10 patents)

29 patents: Sort by Forward Citations

1. 7022500 - Humanized immunoglobulins (2006-04-04),

2. 6933368 - Increasing antibody affinity by altering glycosylation of immunoglobulin variable region (2005-08-23),

3. 6894149 - Anti-HLA-DA antibodies and the methods of using thereof (2005-05-17),

4. 6780586 - Methods of diagnosing breast cancer (2004-08-24),

5. 6762020 - Methods of diagnosing breast cancer (2004-07-13),

6. 6750013 - Methods for detection and diagnosing of breast cancer (2004-06-15),

7. 6682890 - Methods of diagnosing and determining prognosis of colorectal cancer (2004-01-27),

8. 6410824 - Animal model for psoriasis for the prevention and treatment of psoriasis in humans (2002-06-25),

9. 6329511 - Humanized antibodies to &ggr;-interferon (2001-12-11),

10. 6210671 - Humanized antibodies reactive with L-selectin (2001-04-03),

11. 6210670 - Cross-reacting monoclonal antibodies specific for E-selectin and P-selectin (2001-04-03),

12. 6180370 - Humanized immunoglobulins and methods of making the same (2001-01-30),

13. 6129914 - Bispecific antibody effective to treat B-cell lymphoma and cell line (2000-10-10),

14. 6051405 - Constructs encoding recombinant antibody-toxin fusion proteins (2000-04-18),

15. 6046310 - FAS ligand fusion proteins and their uses (2000-04-04),

Protein Design Labs, Inc. is a biopharmaceutical company specializing in the discovery and development of innovative therapeutic monoclonal antibodies. With a focus on improving patient outcomes, Protein Design Labs combines cutting-edge technology and extensive scientific expertise to create new therapies for a wide range of diseases. Through strategic collaborations and its own research and development efforts, the company aims to address unmet medical needs and make a meaningful impact on patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

29 Patents

#68 in Fremont, CA

#2,680 in California

#11,219 in US

#21,844 in the World

Fremont, CA, United States of America

Protein Design Labs, Inc.

Forward Citations = 11,239

31 inventors:

Cary L Queen (14 out of 18 patents)

J Yun Tso (6 out of 48 patents)

Harold E Selick (6 out of 13 patents)

4. Man Sung Co (5 out of 20 patents)

5. Kurt C Gish (4 out of 27 patents)

Please report any incorrect information to support@idiyas.com

Loading…